Zheng et al. offered further explanation by demonstrating that Exenatide improved cardiac function, increased translocation of glucose transporters (GLUTs) and suppressed translocation of fatty acid transporter FAT/CD36 after myocardial ischemia-reperfusion injury. This evidence concerns the gene CD36 and myocardial ischemia.